Dianeal

DRUG5 trials

Sponsors

Vantive Health LLC, Pontifícia Universidade Católica do Paraná, Ottawa Hospital Research Institute

Conditions

APDCAPDDiabetesDisorders Associated With Peritoneal DialysisESRDEnd Stage Renal Disease (ESRD)End-stage Renal Disease (ESRD)Kidney Disease

Phase 3

IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients

CompletedNCT00567398

Vantive Health LLCDiabetes, ESRD

Start: 2008-04-30End: 2011-07-31Updated: 2025-07-22

Dianeal, Extraneal, Nutrineal (D-E-N) Versus Dianeal Only in Diabetic Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients

CompletedNCT01219959

Vantive Health LLCCAPD, Diabetes, End Stage Renal Disease (ESRD)

Start: 2010-10-31End: 2011-07-31Updated: 2025-07-24

Phase 4

IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients

CompletedNCT00567489

Vantive Health LLCAPD, CAPD, Diabetes +1

Start: 2008-01-31End: 2011-07-31Updated: 2025-07-22

Study to Evaluate the Effects Icodextrin Versus Dianeal on Insulin Resistance in Nondiabetic Automated Peritoneal Dialysis Patients

CompletedNCT01021878

Pontifícia Universidade Católica do ParanáDisorders Associated With Peritoneal Dialysis

Start: 2009-10-31End: 2012-02-29Updated: 2014-10-01

Sympathetic Activity in Patients With End-stage Renal Disease on Peritoneal Dialysis

CompletedNCT01228279

Ottawa Hospital Research InstituteEnd-stage Renal Disease (ESRD), Kidney Disease

Start: 2007-07-31End: 2018-12-31Updated: 2021-03-15